Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
113
2.020
 Why?
Thyroidectomy
13
2019
60
1.860
 Why?
Parathyroidectomy
8
2018
46
1.320
 Why?
Thyroid Diseases
6
2019
24
1.270
 Why?
Parathyroid Neoplasms
5
2015
27
1.110
 Why?
Thyroid Gland
7
2017
73
1.050
 Why?
Parathyroid Hormone
8
2019
147
0.970
 Why?
Adenoma
4
2017
112
0.970
 Why?
Vitamin D Deficiency
5
2019
44
0.960
 Why?
Vitamin D
4
2015
88
0.830
 Why?
Fluorodeoxyglucose F18
6
2013
190
0.750
 Why?
Positron-Emission Tomography
7
2013
289
0.740
 Why?
Radiopharmaceuticals
7
2015
205
0.720
 Why?
Carcinoma, Papillary
4
2017
49
0.720
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.700
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.670
 Why?
Hyperparathyroidism
2
2015
31
0.600
 Why?
Iodine Radioisotopes
3
2015
36
0.570
 Why?
Megestrol Acetate
2
2007
17
0.540
 Why?
Parathyroid Diseases
2
2016
5
0.530
 Why?
Bone Density Conservation Agents
2
2007
74
0.520
 Why?
Nursing Homes
2
2007
113
0.520
 Why?
Incidental Findings
3
2013
39
0.490
 Why?
Proton Pump Inhibitors
1
2015
85
0.480
 Why?
Diphosphonates
1
2015
90
0.470
 Why?
Academic Medical Centers
2
2012
147
0.460
 Why?
Thyroglobulin
2
2013
7
0.460
 Why?
Aged
19
2017
9590
0.440
 Why?
Parathyroid Glands
5
2018
20
0.440
 Why?
Carcinoma, Medullary
2
2010
12
0.440
 Why?
Middle Aged
25
2017
12460
0.430
 Why?
Hypothyroidism
2
2011
55
0.390
 Why?
Male
31
2019
25718
0.390
 Why?
Retrospective Studies
14
2019
6223
0.390
 Why?
Calcitonin
2
2010
30
0.370
 Why?
Postoperative Complications
5
2018
1035
0.370
 Why?
Humans
44
2019
50389
0.350
 Why?
Carcinoma
2
2012
139
0.350
 Why?
Algorithms
1
2013
618
0.340
 Why?
Thyroid Nodule
3
2017
31
0.330
 Why?
Female
29
2019
26981
0.320
 Why?
Weight Loss
2
2009
243
0.310
 Why?
Appetite Stimulants
1
2007
5
0.290
 Why?
Aged, 80 and over
9
2017
3180
0.280
 Why?
Cachexia
1
2007
25
0.280
 Why?
Teriparatide
1
2007
10
0.280
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.260
 Why?
Hypocalcemia
2
2016
12
0.260
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.250
 Why?
Calcium
3
2018
401
0.250
 Why?
Phenylurea Compounds
2
2015
15
0.250
 Why?
Hormones
1
2005
57
0.250
 Why?
Osteoporosis
1
2007
156
0.250
 Why?
Quinolines
2
2015
41
0.240
 Why?
Transcriptional Activation
1
2005
121
0.240
 Why?
Pituitary Gland
1
2005
89
0.240
 Why?
Receptors, Estrogen
1
2005
130
0.240
 Why?
Interleukin-6
1
2005
266
0.230
 Why?
NF-kappa B
1
2005
315
0.220
 Why?
Protein Kinase Inhibitors
2
2015
205
0.220
 Why?
Biopsy, Fine-Needle
5
2011
108
0.220
 Why?
Illinois
2
2013
10
0.210
 Why?
Treatment Outcome
8
2015
5230
0.200
 Why?
Adult
13
2017
13568
0.190
 Why?
Gene Expression Regulation
1
2005
964
0.180
 Why?
Aging
1
2005
675
0.180
 Why?
Young Adult
7
2015
4064
0.170
 Why?
Follow-Up Studies
3
2013
2219
0.170
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
 Why?
Postoperative Period
3
2015
170
0.160
 Why?
Preoperative Care
2
2018
170
0.150
 Why?
Vitamins
2
2018
63
0.150
 Why?
Patient Discharge
3
2016
322
0.150
 Why?
Intraoperative Complications
1
2019
113
0.140
 Why?
Insulin Resistance
2
2009
264
0.140
 Why?
United States
5
2015
4913
0.140
 Why?
Antineoplastic Agents
2
2015
1178
0.140
 Why?
Prospective Studies
2
2013
2414
0.140
 Why?
Predictive Value of Tests
3
2015
934
0.130
 Why?
Reoperation
1
2018
457
0.130
 Why?
Incidence
2
2011
1017
0.130
 Why?
Adolescent
5
2015
6475
0.130
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
23
0.120
 Why?
Creatinine
1
2015
144
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
50
0.120
 Why?
Costs and Cost Analysis
2
2014
92
0.120
 Why?
Disease Progression
3
2015
823
0.120
 Why?
Lymph Nodes
1
2017
258
0.120
 Why?
Molecular Targeted Therapy
1
2015
121
0.120
 Why?
Diagnosis, Differential
6
2018
1042
0.120
 Why?
Ambulatory Care
1
2016
228
0.110
 Why?
Neoplasm Metastasis
2
2015
235
0.110
 Why?
Hospitals, University
1
2014
78
0.110
 Why?
Child, Preschool
2
2013
3908
0.110
 Why?
Exercise
2
2009
505
0.110
 Why?
Liver
2
2009
1123
0.110
 Why?
Sensitivity and Specificity
2
2013
875
0.110
 Why?
Drug Administration Schedule
1
2013
369
0.100
 Why?
Hospitals, Teaching
1
2013
54
0.100
 Why?
Technetium
1
2012
9
0.100
 Why?
Administration, Oral
1
2013
432
0.100
 Why?
Preoperative Period
1
2012
48
0.100
 Why?
Radionuclide Imaging
1
2012
116
0.100
 Why?
Outpatients
1
2013
115
0.100
 Why?
Patient Compliance
1
2013
231
0.100
 Why?
Clinical Competence
2
2018
397
0.100
 Why?
Hospital Charges
1
2012
44
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Tumor Burden
1
2012
131
0.100
 Why?
Cost Savings
1
2012
58
0.100
 Why?
Child
3
2013
6877
0.100
 Why?
Prognosis
3
2015
1979
0.100
 Why?
Ovariectomy
1
2012
113
0.100
 Why?
Immunohistochemistry
2
2012
975
0.090
 Why?
Obesity
2
2009
1125
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1356
0.090
 Why?
Radiation Monitoring
1
2010
7
0.090
 Why?
Checklist
1
2010
30
0.090
 Why?
Inpatients
1
2011
193
0.090
 Why?
Radiosurgery
1
2011
121
0.090
 Why?
Fatal Outcome
1
2010
195
0.080
 Why?
Databases, Factual
1
2013
667
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
34
0.080
 Why?
Ultrasonography
4
2015
438
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
General Surgery
1
2010
107
0.080
 Why?
Occupational Exposure
1
2010
111
0.080
 Why?
Receptors, Thyrotropin
1
2007
7
0.070
 Why?
Blastomycosis
1
2008
62
0.070
 Why?
Symporters
1
2007
17
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2934
0.070
 Why?
Ovarian Neoplasms
1
2012
450
0.070
 Why?
Severity of Illness Index
1
2011
963
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Whole Body Imaging
1
2007
26
0.070
 Why?
Adiposity
1
2009
133
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Promoter Regions, Genetic
2
2007
467
0.070
 Why?
Drug Utilization Review
1
2006
23
0.070
 Why?
Drug Monitoring
1
2006
78
0.070
 Why?
Head
1
2006
70
0.070
 Why?
Cross-Sectional Studies
2
2014
1590
0.070
 Why?
Geriatrics
1
2006
45
0.070
 Why?
Gene Expression Regulation, Neoplastic
1
2010
830
0.070
 Why?
Body Mass Index
2
2009
669
0.070
 Why?
Otolaryngology
1
2006
58
0.070
 Why?
Neck
1
2006
99
0.060
 Why?
Proportional Hazards Models
1
2007
418
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
9
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Faculty, Medical
1
2006
92
0.060
 Why?
Arkansas
2
2014
1991
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Fractures, Bone
1
2006
109
0.060
 Why?
Survival Analysis
1
2007
671
0.060
 Why?
DNA Primers
1
2005
208
0.060
 Why?
Reproducibility of Results
3
2017
1201
0.060
 Why?
HeLa Cells
1
2005
257
0.060
 Why?
Internship and Residency
1
2010
444
0.060
 Why?
Base Sequence
1
2005
657
0.060
 Why?
Nuclear Proteins
1
2005
244
0.060
 Why?
Protein Binding
1
2005
657
0.050
 Why?
Infant
1
2012
3601
0.050
 Why?
ROC Curve
2
2015
239
0.050
 Why?
Patient Selection
2
2018
257
0.050
 Why?
Intraoperative Period
2
2015
45
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
556
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1160
0.040
 Why?
Thalidomide
1
2002
374
0.040
 Why?
Cohort Studies
2
2015
1426
0.040
 Why?
Glucagon
2
2009
22
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
3692
0.040
 Why?
Pilot Projects
2
2010
704
0.040
 Why?
Methylene Blue
1
2017
9
0.040
 Why?
Lymphatic System
1
2017
13
0.040
 Why?
Societies, Medical
1
2018
179
0.040
 Why?
Animals, Genetically Modified
1
2017
48
0.040
 Why?
Coloring Agents
1
2017
70
0.030
 Why?
Mice, Inbred Strains
1
2017
160
0.030
 Why?
Insulin
2
2009
466
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
78
0.030
 Why?
Recurrence
1
2018
664
0.030
 Why?
Lymphatic Metastasis
1
2017
227
0.030
 Why?
Bone Density
1
2018
385
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
57
0.030
 Why?
Brachial Plexus
1
2015
13
0.030
 Why?
Endocrinology
1
2015
9
0.030
 Why?
Axilla
1
2015
91
0.030
 Why?
Hematoma
1
2015
64
0.030
 Why?
Transplantation, Autologous
1
2015
464
0.030
 Why?
Neoplasm Staging
1
2015
750
0.030
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
24
0.020
 Why?
Mutation
1
2017
1292
0.020
 Why?
Ribs
1
2010
15
0.020
 Why?
Thoracotomy
1
2010
35
0.020
 Why?
Neck Dissection
1
2010
30
0.020
 Why?
Mediastinal Neoplasms
1
2010
19
0.020
 Why?
Hypercalcemia
1
2010
33
0.020
 Why?
Feasibility Studies
1
2011
386
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
66
0.020
 Why?
Hospitalization
1
2014
668
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
970
0.020
 Why?
Glucose Tolerance Test
1
2009
57
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Postmenopause
1
2009
77
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
234
0.020
 Why?
Absorptiometry, Photon
1
2009
155
0.020
 Why?
Eye
1
2008
24
0.020
 Why?
Bone Neoplasms
1
2010
179
0.020
 Why?
Iodine
1
2007
10
0.020
 Why?
Methylation
1
2007
118
0.020
 Why?
Body Weight
1
2009
514
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
634
0.020
 Why?
Multiple Myeloma
1
2002
2949
0.020
 Why?
Overweight
1
2009
217
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5688
0.020
 Why?
Office Visits
1
2006
41
0.020
 Why?
Polymerase Chain Reaction
1
2007
456
0.020
 Why?
Genetic Predisposition to Disease
1
2009
509
0.020
 Why?
Blood Glucose
1
2009
443
0.020
 Why?
Risk Assessment
1
2010
1258
0.020
 Why?
Lung
1
2008
512
0.010
 Why?
Muscle, Skeletal
1
2009
781
0.010
 Why?
Thyroid Function Tests
1
2002
24
0.010
 Why?
Thyrotropin
1
2002
47
0.010
 Why?
Animals
1
2017
13173
0.010
 Why?
Clinical Trials as Topic
1
2002
465
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department